The Effectiveness of Internet-Based Hope Therapy on Coping Strategies in Patients with Prostate Cancer
Downloads
Background: Most men have prostate cancer (PC), the second leading cause of death. The current study aimed to investigate the effectiveness of Internet-based hope therapy on coping strategies in men with PC.
Methods: A quasi-experimental research with a pretest-posttest design and a control group was used in this study. 317 men with PC were referred to the King Fahd Medical City in Riyadh, Saudi Arabia, in 2020. Following the participants' voluntary selection, the pre-test stage was performed, and they were given the Coping Inventory for Stressful Situations (CISS). Subjects were chosen by simple random sampling and divided into two groups of 25 experimental and control subjects. Before taking the post-test, the experimental group received hope therapy training. The data were analyzed using multivariate analysis of covariance (MANCOVA) and SPSS software.
Results: There was a significant difference between the experimental and control groups regarding stress (F = 57.495, P < 0.001), problem-oriented strategy (F = 33.041, P < 0.001), excitement strategy (F = 28.491, P < 0.001), and circuit avoidance strategy (F = 87.138, P < 0.001) variables. As a result, it can be concluded that the intervention was effective, and the experimental group outperformed the control group in the post-test stage.
Conclusion: Hope therapy has a good effect on reducing stress in patients with PC and can be used to reduce the negative psychological consequences and increase effective coping strategies with stress.
Downloads
Afshar-Oromieh, A., Debus, N., Uhrig, M., Hope, T. A., Evans, M. J., Holland-Letz, T. et al. (2018). Impact of long-term androgen deprivation therapy on PSMA ligand PET/CT in patients with castration-sensitive prostate cancer. Eur J Nucl.Med Mol.Imaging., 45(12), 2045-2054. doi:10.1007/s00259-018-4079-z [doi];10.1007/s00259-018-4079-z [pii]. Retrieved from PM:29980832
Aggarwal, R., Wei, X., Kim, W., Small, E. J., Ryan, C. J., Carroll, P. et al. (2018). Heterogeneous flare in prostate-specific membrane antigen positron emission tomography tracer uptake with initiation of androgen pathway blockade in metastatic prostate cancer. Eur Urol.Oncol., 1 (1), 78-82. doi:S2588-9311(18)30019-1 [pii];10.1016/j.euo.2018.03.010 [doi]. Retrieved from PM:31100231
Anderson, N. B., Bulatao, R. A., & Cohen, B. (2004). Critical perspectives on racial and ethnic differences in health in late life. Washington, DC: National Academies Press.
Azarnik, M. (2019). The effectiveness of mindfulness-based cognitive therapy on quality of life in relation to health and self-efficacy in patients with rheumatoid arthritis. Int J Body Mind Culture, 6(1), 21-26.
Bjartell, A. (2019). New hope in prostate cancer precision medicine? miRNA replacement and epigenetics. Clin Cancer Res, 25(9), 2679-2681. doi:1078-0432.CCR-19-0061 [pii];10.1158/1078-0432.CCR-19-0061 [doi]. Retrieved from PM:30808772
Calais, J., Armstrong, W. R., Kishan, A. U., Booker, K. M., Hope, T. A., Fendler, W. P. et al. (2021). Update from PSMA-SRT Trial NCT03582774: A Randomized phase 3 imaging trial of prostate-specific membrane antigen positron emission tomography for salvage radiation therapy for prostate cancer recurrence powered for clinical outcome. Eur Urol.Focus., 7(2), 238-240. doi:S2405-4569(20)30311-4 [pii];10.1016/j.euf.2020.12.009 [doi]. Retrieved from PM:33386288
Craig, E. L., Stopsack, K. H., Evergren, E., Penn, L. Z., Freedland, S. J., Hamilton, R. J. et al. (2022). Statins and prostate cancer-hype or hope? The epidemiological perspective. Prostate.Cancer Prostatic.Dis.. doi:10.1038/s41391-022-00554-1 [doi];10.1038/s41391-022-00554-1 [pii]. Retrieved from PM:35732821
Dong, Y., Chen, Y., Zhu, D., Shi, K., Ma, C., Zhang, W. et al. (2020). Self-assembly of amphiphilic phospholipid peptide dendrimer-based nanovectors for effective delivery of siRNA therapeutics in prostate cancer therapy. J Control Release., 322, 416-425. doi:S0168-3659(20)30212-1 [pii];10.1016/j.jconrel.2020.04.003 [doi]. Retrieved from PM:32247806
Endler, N. S., Parker, J. D. A., Ridder, D. T. D., & van Heck, G. L. (1990). Coping inventory for stressful situations. Toronto, Canada: Multi-Health systems Incorporated.
Faryabi, M., Rafieipour, A., Haji-Alizadeh, K., & Khodavardian, S. (2022). Comparison of the effectiveness of cognitive-behavioral therapy and acceptance and commitment therapy on anxiety, perceived stress, and pain coping strategies in patients with cancer. Int J Body Mind Culture, 8(1), 55-64.
Fendler, W. P., Ferdinandus, J., Czernin, J., Eiber, M., Flavell, R. R., Behr, S. C. et al. (2020). Impact of (68)Ga-PSMA-11 PET on the management of recurrent prostate cancer in a prospective single-arm clinical trial. J Nucl.Med, 61(12), 1793-1799. doi:jnumed.120.242180 [pii];10.2967/jnumed.120.242180 [doi]. Retrieved from PM:32358094
Foroozanfar, F., & Ansari-Shahidi, M. (2020). The effectiveness of acceptance and commitment therapy on self-care behavior and hope in patients with irritable bowel syndrome in Isfahan, Iran. Int J Body Mind Culture, 7(2), 82-88. Retrieved from https://ijbmc.org/index.php/ijbmc/article/view/207
Green N.S. (2004). The anatomy of hope: How people prevail in the face of illness. J Clin Investig, 113(11), 1514.
Helsmoortel, H., Everaert, C., Lumen, N., Ost, P., & Vandesompele, J. (2018). Detecting long non-coding RNA biomarkers in prostate cancer liquid biopsies: Hype or hope? Noncoding.RNA.Res, 3(2), 64-74. doi:10.1016/j.ncrna.2018.05.001 [doi];S2468-0540(17)30054-9 [pii]. Retrieved from PM:30159441
Jindal, V. (2018). Immunotherapy: A glimmer of hope for metastatic prostate cancer. Chin.Clin Oncol., 7(6), 61. doi:cco.2018.02.01 [pii];10.21037/cco.2018.02.01 [doi]. Retrieved from PM:29860848
Mao, N., Zhang, Z., Lee, Y. S., Choi, D., Rivera, A. A., Li, D. et al. (2021). Defining the therapeutic selective dependencies for distinct subtypes of PI3K pathway-altered prostate cancers. Nat.Commun, 12(1), 5053. doi:10.1038/s41467-021-25341-9 [doi];10.1038/s41467-021-25341-9 [pii]. Retrieved from PM:34417459
Masters, J. R., Kane, C., Yamamoto, H., & Ahmed, A. (2008). Prostate cancer stem cell therapy: hype or hope? Prostate.Cancer Prostatic.Dis., 11(4), 316-319. doi:pcan200822 [pii];10.1038/pcan.2008.22 [doi]. Retrieved from PM:18427568
McWilliams, L. A., Cox, B. J., & Enns, M. W. (2003). Use of the Coping Inventory for Stressful Situations in a clinically depressed sample: Factor structure, personality correlates, and prediction of distress. J Clin Psychol, 59(4), 423-437. doi:10.1002/jclp.10080 [doi]. Retrieved from PM:12652635
Pal, S. K., Moreira, D., Won, H., White, S. W., Duttagupta, P., Lucia, M. et al. (2019). Reduced T-cell Numbers and elevated levels of immunomodulatory cytokines in metastatic prostate cancer patients de novo resistant to abiraterone and/or enzalutamide therapy. Int J Mol.Sci, 20(8). doi:ijms20081831 [pii];10.3390/ijms20081831 [doi]. Retrieved from PM:31013891
Rafnsson, F. D., Smari, J., Windle, M., Mears, S. A., & Endler, N. S. (2006). Factor structure and psychometric characteristics of the Icelandic version of the Coping Inventory for Stressful Situations (CISS). Pers Individ Differ, 40(6), 1247-1258.
Rekoske, B. T., & McNeel, D. G. (2016). Immunotherapy for prostate cancer: False promises or true hope? Cancer, 122(23), 3598-3607. doi:10.1002/cncr.30250 [doi]. Retrieved from PM:27649312
Roach, M 3rd, Kurhanewicz, J., & Carroll, P. (2001). Spectroscopy in prostate cancer: hope or hype? Oncology (Williston.Park.), 15(11), 1399-1410. doi:172089 [pii]. Retrieved from PM:11758871
Salavati, A., Gencturk, M., Koksel, Y., Schik, A. N., Carroll, P. R., Feng, F. Y. et al. (2021). A bicentric retrospective analysis of clinical utility of (18)F-fluciclovine PET in biochemically recurrent prostate cancer following primary radiation therapy: Is it helpful in patients with a PSA rise less than the Phoenix criteria? Eur J Nucl.Med Mol.Imaging., 48(13), 4463-4471. doi:10.1007/s00259-021-05415-y [doi];10.1007/s00259-021-05415-y [pii]. Retrieved from PM:34091713
Saranyutanon, S., Srivastava, S. K., Pai, S., Singh, S., & Singh, A. P. (2019). Therapies targeted to androgen receptor signaling axis in prostate cancer: Progress, challenges, and hope. Cancers.(Basel.), 12(1). doi:cancers12010051 [pii];10.3390/cancers12010051 [doi]. Retrieved from PM:31877956
Schoder, H., Hope, T. A., Knopp, M., Kelly, W. K., Michalski, J. M., Lerner, S. P. et al. (2022). Considerations on integrating prostate-specific membrane antigen positron emission tomography imaging into clinical prostate cancer trials by national clinical trials network cooperative groups. J Clin Oncol., 40(13), 1500-1505. doi:10.1200/JCO.21.02440 [doi]. Retrieved from PM:35015566
Shen, D., Ju, L., Zhou, F., Yu, M., Ma, H., Zhang, Y. et al. (2021). The inhibitory effect of melatonin on human prostate cancer. Cell Commun Signal, 19(1), 34. doi:10.1186/s12964-021-00723-0 [doi];10.1186/s12964-021-00723-0 [pii]. Retrieved from PM:33722247
Snyder, C. R., & Lopez, S. J. (2001). Handbook of positive psychology. Oxford, UK: Oxford University Press.
Wang, S., Blaha, C., Santos, R., Huynh, T., Hayes, T. R., Beckford-Vera, D. R. et al. (2019). Synthesis and initial biological evaluation of boron-containing prostate-specific membrane antigen ligands for treatment of prostate cancer using boron neutron capture therapy. Mol.Pharm, 16(9), 3831-3841. doi:10.1021/acs.molpharmaceut.9b00464 [doi]. Retrieved from PM:31381351
Copyright (c) 2022 International Journal of Body, Mind and Culture
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
